{
  "2": [
    {
      "name": "CB1",
      "type": "checkbox",
      "page": 2,
      "field_label": "Start of treatment",
      "question": "Is this request for the start of a new treatment for the patient?",
      "context": "Initial checkbox in treatment timeline section indicating whether patient is beginning new therapy."
    },
    {
      "name": "T2",
      "type": "text",
      "page": 2,
      "field_label": "Start date: (MM)",
      "question": "What is the two-digit month for the treatment start date?",
      "context": "Month component for the planned medication initiation date in treatment scheduling section."
    },
    {
      "name": "T3",
      "type": "text",
      "page": 2,
      "field_label": "Start date: (DD)",
      "question": "What is the two-digit day for the treatment start date?",
      "context": "Day component for the planned medication initiation date in treatment scheduling section."
    },
    {
      "name": "T4",
      "type": "text",
      "page": 2,
      "field_label": "Start date: (YYYY)",
      "question": "What is the four-digit year for the treatment start date?",
      "context": "Year component for the planned medication initiation date in treatment scheduling section."
    },
    {
      "name": "CB5",
      "type": "checkbox",
      "page": 2,
      "field_label": "Continuation of therapy",
      "question": "Is this request for the continuation of an existing therapy for the patient?",
      "context": "Checkbox indicating if the request is for ongoing treatment, as opposed to new initiation."
    },
    {
      "name": "T6",
      "type": "text",
      "page": 2,
      "field_label": "Date of last treatment: (MM)",
      "question": "What is the two-digit month of the patient's last treatment?",
      "context": "Month component for the last treatment date, required for continuation of therapy requests."
    },
    {
      "name": "T7",
      "type": "text",
      "page": 2,
      "field_label": "Date of last treatment: (DD)",
      "question": "What is the two-digit day of the patient's last treatment?",
      "context": "Day component for the last treatment date, required for continuation of therapy requests."
    },
    {
      "name": "T8",
      "type": "text",
      "page": 2,
      "field_label": "Date of last treatment: (YYYY)",
      "question": "What is the four-digit year of the patient's last treatment?",
      "context": "Year component for the last treatment date, required for continuation of therapy requests."
    },
    {
      "name": "T9",
      "type": "text",
      "page": 2,
      "field_label": "Precertification Requested By:",
      "question": "Who is submitting this precertification request?",
      "context": "Identifies the individual or entity responsible for submitting the prior authorization request."
    },
    {
      "name": "T10",
      "type": "text",
      "page": 2,
      "field_label": "Phone:",
      "question": "What is the phone number of the person requesting precertification?",
      "context": "Contact phone number for follow-up regarding the submitted precertification request."
    },
    {
      "name": "T11",
      "type": "text",
      "page": 2,
      "field_label": "Fax:",
      "question": "What is the fax number of the person requesting precertification?",
      "context": "Contact fax number for sending or receiving precertification-related documents."
    },
    {
      "name": "T12",
      "type": "text",
      "page": 2,
      "field_label": "Patient First Name",
      "question": "What is the patient's first name?",
      "context": "Primary demographic information for patient identification in the Patient Information section."
    },
    {
      "name": "T13",
      "type": "text",
      "page": 2,
      "field_label": "Patient Last Name",
      "question": "What is the patient's last name?",
      "context": "Primary demographic information for patient identification in the Patient Information section."
    },
    {
      "name": "T14",
      "type": "text",
      "page": 2,
      "field_label": "Patient DOB (MM/DD/YYYY)",
      "question": "What is the patient's date of birth (MM/DD/YYYY)?",
      "context": "Patient's full date of birth, essential for age verification and accurate record matching."
    },
    {
      "name": "T15",
      "type": "text",
      "page": 2,
      "field_label": "Address:",
      "question": "What is the patient's home address?",
      "context": "Patient's residential street address for contact and demographic records."
    },
    {
      "name": "T16",
      "type": "text",
      "page": 2,
      "field_label": "City:",
      "question": "What is the patient's home city?",
      "context": "Patient's city of residence, part of the complete home address."
    },
    {
      "name": "T17",
      "type": "text",
      "page": 2,
      "field_label": "State:",
      "question": "What is the patient's home state?",
      "context": "Patient's state of residence, part of the complete home address."
    },
    {
      "name": "T18",
      "type": "text",
      "page": 2,
      "field_label": "ZIP:",
      "question": "What is the patient's home ZIP code?",
      "context": "Patient's ZIP code, completing the demographic home address details."
    },
    {
      "name": "T19",
      "type": "text",
      "page": 2,
      "field_label": "Patient Phone",
      "question": "What is the patient's home phone number?",
      "context": "Patient's primary home contact number for communication purposes."
    },
    {
      "name": "T20",
      "type": "text",
      "page": 2,
      "field_label": "Work Phone:",
      "question": "What is the patient's work phone number?",
      "context": "Patient's alternative work contact number, if applicable, for communication."
    },
    {
      "name": "T21",
      "type": "text",
      "page": 2,
      "field_label": "Cell Phone:",
      "question": "What is the patient's cell phone number?",
      "context": "Patient's mobile contact number, important for direct communication."
    },
    {
      "name": "T22",
      "type": "text",
      "page": 2,
      "field_label": "E-mail:",
      "question": "What is the patient's email address?",
      "context": "Patient's email address for electronic communication and record-keeping."
    },
    {
      "name": "T24",
      "type": "text",
      "page": 2,
      "field_label": "lbs",
      "question": "What is the patient's current weight in pounds (lbs)?",
      "context": "Patient's current weight in pounds, used for calculating medication dosage and clinical assessment."
    },
    {
      "name": "T25",
      "type": "text",
      "page": 2,
      "field_label": "kgs",
      "question": "What is the patient's current weight in kilograms (kgs)?",
      "context": "Patient's current weight in kilograms, alternative unit for medication dosage calculation."
    },
    {
      "name": "T26",
      "type": "text",
      "page": 2,
      "field_label": "inches",
      "question": "What is the patient's current height in inches?",
      "context": "Patient's current height in inches, used for Body Surface Area (BSA) calculations."
    },
    {
      "name": "T27",
      "type": "text",
      "page": 2,
      "field_label": "cms",
      "question": "What is the patient's current height in centimeters (cms)?",
      "context": "Patient's current height in centimeters, alternative unit for BSA calculations."
    },
    {
      "name": "T23",
      "type": "text",
      "page": 2,
      "field_label": "Allergies:",
      "question": "What are the patient's known allergies?",
      "context": "Lists all patient allergies, critical for medication safety and preventing adverse reactions."
    },
    {
      "name": "T28",
      "type": "text",
      "page": 2,
      "field_label": "Member ID #:",
      "question": "What is the patient's insurance member ID number?",
      "context": "Patient's unique insurance identification number for eligibility and benefits verification."
    },
    {
      "name": "T29",
      "type": "text",
      "page": 2,
      "field_label": "Group #:",
      "question": "What is the patient's insurance group number?",
      "context": "Patient's insurance group number, identifying their specific plan or employer group."
    },
    {
      "name": "T30",
      "type": "text",
      "page": 2,
      "field_label": "Insured:",
      "question": "Who is the primary insured party on the patient's policy?",
      "context": "Name of the primary policyholder if different from the patient, for insurance verification."
    },
    {
      "name": "CB31",
      "type": "checkbox",
      "page": 2,
      "field_label": "Yes",
      "question": "Does the patient have other insurance coverage?",
      "context": "Indicates if the patient has additional primary or secondary health insurance coverage."
    },
    {
      "name": "CB32",
      "type": "checkbox",
      "page": 2,
      "field_label": "No",
      "question": "Does the patient not have other insurance coverage?",
      "context": "Indicates if the patient solely relies on this insurance, without other coverage."
    },
    {
      "name": "T33",
      "type": "text",
      "page": 2,
      "field_label": "If yes, provide ID#:",
      "question": "If yes, what is the ID number for the patient's other coverage?",
      "context": "Requires the ID number for any additional insurance coverage the patient may have."
    },
    {
      "name": "T34",
      "type": "text",
      "page": 2,
      "field_label": "Carrier Name:",
      "question": "What is the carrier name of the patient's other insurance?",
      "context": "Name of the insurance company providing the patient's other health coverage."
    },
    {
      "name": "T35",
      "type": "text",
      "page": 2,
      "field_label": "Insured:",
      "question": "Who is the primary insured party on the patient's other policy?",
      "context": "Name of the primary policyholder for the patient's other insurance coverage."
    },
    {
      "name": "T42",
      "type": "text",
      "page": 2,
      "field_label": "First Name:",
      "question": "What is the prescriber's first name?",
      "context": "Prescriber's first name for identification and verification in the Prescriber Information section."
    },
    {
      "name": "T43",
      "type": "text",
      "page": 2,
      "field_label": "Last Name:",
      "question": "What is the prescriber's last name?",
      "context": "Prescriber's last name for identification and verification in the Prescriber Information section."
    },
    {
      "name": "CB44",
      "type": "checkbox",
      "page": 2,
      "field_label": "M.D.",
      "question": "Is the prescriber an M.D. (Medical Doctor)?",
      "context": "Prescriber's professional credential (Medical Doctor) for licensing and qualification verification."
    },
    {
      "name": "CB45",
      "type": "checkbox",
      "page": 2,
      "field_label": "D.O.",
      "question": "Is the prescriber a D.O. (Doctor of Osteopathic Medicine)?",
      "context": "Prescriber's professional credential (Doctor of Osteopathic Medicine) for licensing verification."
    },
    {
      "name": "CB46",
      "type": "checkbox",
      "page": 2,
      "field_label": "N.P.",
      "question": "Is the prescriber an N.P. (Nurse Practitioner)?",
      "context": "Prescriber's professional credential (Nurse Practitioner) for licensing and qualification verification."
    },
    {
      "name": "CB47",
      "type": "checkbox",
      "page": 2,
      "field_label": "P.A.",
      "question": "Is the prescriber a P.A. (Physician Assistant)?",
      "context": "Prescriber's professional credential (Physician Assistant) for licensing and qualification verification."
    },
    {
      "name": "T48",
      "type": "text",
      "page": 2,
      "field_label": "Address:",
      "question": "What is the prescriber's office address?",
      "context": "Prescriber's primary office street address for contact and record-keeping."
    },
    {
      "name": "T49",
      "type": "text",
      "page": 2,
      "field_label": "City:",
      "question": "What is the city of the prescriber's office?",
      "context": "City of the prescriber's office, part of the complete office address."
    },
    {
      "name": "T50",
      "type": "text",
      "page": 2,
      "field_label": "State:",
      "question": "What is the state of the prescriber's office?",
      "context": "State of the prescriber's office, part of the complete office address."
    },
    {
      "name": "T51",
      "type": "text",
      "page": 2,
      "field_label": "ZIP:",
      "question": "What is the ZIP code of the prescriber's office?",
      "context": "ZIP code of the prescriber's office, completing the office address details."
    },
    {
      "name": "T52",
      "type": "text",
      "page": 2,
      "field_label": "Phone:",
      "question": "What is the prescriber's office phone number?",
      "context": "Prescriber's primary office contact number for direct communication."
    },
    {
      "name": "T53",
      "type": "text",
      "page": 2,
      "field_label": "Fax:",
      "question": "What is the prescriber's office fax number?",
      "context": "Prescriber's office fax number for sending or receiving medical documentation."
    },
    {
      "name": "T54",
      "type": "text",
      "page": 2,
      "field_label": "St Lic #:",
      "question": "What is the prescriber's state license number?",
      "context": "Prescriber's state medical license number, essential for verification of credentials."
    },
    {
      "name": "T55",
      "type": "text",
      "page": 2,
      "field_label": "NPI #:",
      "question": "What is the prescriber's NPI (National Provider Identifier) number?",
      "context": "Prescriber's unique NPI for standardized identification in healthcare transactions."
    },
    {
      "name": "T56",
      "type": "text",
      "page": 2,
      "field_label": "DEA #:",
      "question": "What is the prescriber's DEA (Drug Enforcement Administration) number?",
      "context": "Prescriber's DEA registration number, required for prescribing controlled substances."
    },
    {
      "name": "T57",
      "type": "text",
      "page": 2,
      "field_label": "UPIN:",
      "question": "What is the prescriber's UPIN (Unique Physician Identification Number)?",
      "context": "Prescriber's UPIN, if applicable, for physician identification (legacy identifier)."
    },
    {
      "name": "T58.0",
      "type": "text",
      "page": 2,
      "field_label": "Provider Email:",
      "question": "What is the prescriber's email address?",
      "context": "Prescriber's email address for electronic communication regarding patient care."
    },
    {
      "name": "T58.1",
      "type": "text",
      "page": 2,
      "field_label": "Office Contact Name:",
      "question": "What is the name of the primary contact person at the prescriber's office?",
      "context": "Name of a key administrative contact at the prescriber's office for PA inquiries."
    },
    {
      "name": "T59",
      "type": "text",
      "page": 2,
      "field_label": "Phone:",
      "question": "What is the phone number for the prescriber's office contact?",
      "context": "Direct phone number for the specified office contact person, if different from main office."
    },
    {
      "name": "Provider Admin CB.1",
      "type": "checkbox",
      "page": 2,
      "field_label": "Self-administered",
      "question": "Is the medication self-administered by the patient?",
      "context": "Indicates if the patient takes the medication independently, affecting dispensing location."
    },
    {
      "name": "Provider Admin CB.2",
      "type": "checkbox",
      "page": 2,
      "field_label": "Physician’s Office",
      "question": "Will the medication be administered in the physician's office?",
      "context": "Indicates the medication will be administered at the prescriber's office, common for infused drugs."
    },
    {
      "name": "Provider Admin CB.3",
      "type": "checkbox",
      "page": 2,
      "field_label": "Home",
      "question": "Will the medication be administered at the patient's home?",
      "context": "Indicates if the patient will receive the medication at home, common for home health services."
    },
    {
      "name": "Provider Admin CB.4",
      "type": "checkbox",
      "page": 2,
      "field_label": "Outpatient Infusion Center",
      "question": "Will the medication be administered at an outpatient infusion center?",
      "context": "Indicates administration at a dedicated outpatient infusion facility."
    },
    {
      "name": "Provider Admin T.5",
      "type": "text",
      "page": 2,
      "field_label": "Name:",
      "question": "What is the name of the outpatient infusion center?",
      "context": "Name of the specific outpatient infusion center where medication will be administered."
    },
    {
      "name": "Provider Admin CB.7",
      "type": "checkbox",
      "page": 2,
      "field_label": "Home Infusion Center",
      "question": "Will the medication be administered by a home infusion center?",
      "context": "Indicates if a specialized home infusion service will administer the medication at home."
    },
    {
      "name": "Provider Admin T.6",
      "type": "text",
      "page": 2,
      "field_label": "Phone:",
      "question": "What is the phone number of the home infusion center?",
      "context": "Phone number of the home infusion center for scheduling and coordination."
    },
    {
      "name": "Provider Admin T.8",
      "type": "text",
      "page": 2,
      "field_label": "Agency Name:",
      "question": "What is the name of the home infusion agency?",
      "context": "Name of the home infusion agency providing services, if applicable."
    },
    {
      "name": "Provider Admin CB.10",
      "type": "checkbox",
      "page": 2,
      "field_label": "Administration code(s)",
      "question": "Are administration code(s) being provided for this request?",
      "context": "Checkbox to indicate if relevant CPT administration codes will be included for the service."
    },
    {
      "name": "Provider Admin T.9",
      "type": "text",
      "page": 2,
      "field_label": "CPT:",
      "question": "What are the CPT administration code(s) for this service?",
      "context": "Specific CPT codes for the medication's administration, vital for billing and service description."
    },
    {
      "name": "Provider Admin T.11A",
      "type": "text",
      "page": 2,
      "field_label": "Address:",
      "question": "What is the address for the dispensing provider/administration location?",
      "context": "Street address of the dispensing provider or administration facility."
    },
    {
      "name": "Provider Admin T.13",
      "type": "text",
      "page": 2,
      "field_label": "City:",
      "question": "What is the city for the dispensing provider/administration location?",
      "context": "City of the dispensing provider or administration facility."
    },
    {
      "name": "Provider Admin T.14",
      "type": "text",
      "page": 2,
      "field_label": "State:",
      "question": "What is the state for the dispensing provider/administration location?",
      "context": "State of the dispensing provider or administration facility."
    },
    {
      "name": "Provider Admin T.15",
      "type": "text",
      "page": 2,
      "field_label": "ZIP:",
      "question": "What is the ZIP code for the dispensing provider/administration location?",
      "context": "ZIP code of the dispensing provider or administration facility."
    },
    {
      "name": "Provider Admin T.16",
      "type": "text",
      "page": 2,
      "field_label": "Phone:",
      "question": "What is the phone number for the dispensing provider/administration location?",
      "context": "Contact phone number for the dispensing provider or administration facility."
    },
    {
      "name": "Provider Admin T.17A",
      "type": "text",
      "page": 2,
      "field_label": "Fax:",
      "question": "What is the fax number for the dispensing provider/administration location?",
      "context": "Fax number for the dispensing provider or administration facility for document transmission."
    },
    {
      "name": "Provider Admin T.18",
      "type": "text",
      "page": 2,
      "field_label": "TIN:",
      "question": "What is the Tax Identification Number (TIN) for the dispensing provider/administration location?",
      "context": "TIN of the dispensing provider or administration facility, used for tax and billing purposes."
    },
    {
      "name": "Provider Admin T.19",
      "type": "text",
      "page": 2,
      "field_label": "PIN:",
      "question": "What is the Provider Identification Number (PIN) for the dispensing provider/administration location?",
      "context": "PIN of the dispensing provider or administration facility for unique identification."
    },
    {
      "name": "Provider Admin T.20",
      "type": "text",
      "page": 2,
      "field_label": "NPI:",
      "question": "What is the NPI (National Provider Identifier) for the dispensing provider/administration location?",
      "context": "NPI of the dispensing provider or administration facility for standardized identification."
    },
    {
      "name": "Provider Admin CB.21",
      "type": "checkbox",
      "page": 2,
      "field_label": "Outpatient Dialysis Center",
      "question": "Will the medication be dispensed/administered at an outpatient dialysis center?",
      "context": "Checkbox indicating if the medication will be provided by an outpatient dialysis center."
    },
    {
      "name": "Provider Admin CB.22",
      "type": "checkbox",
      "page": 2,
      "field_label": "Physician’s Office",
      "question": "Will the medication be dispensed/administered at a physician's office?",
      "context": "Checkbox indicating if the medication will be provided by a physician's office."
    },
    {
      "name": "Provider Admin CB.23.0.0",
      "type": "checkbox",
      "page": 2,
      "field_label": "Retail Pharmacy",
      "question": "Will the medication be dispensed by a retail pharmacy?",
      "context": "Checkbox indicating if the medication will be obtained from a retail pharmacy."
    },
    {
      "name": "Provider Admin CB.24.0.0",
      "type": "checkbox",
      "page": 2,
      "field_label": "Specialty Pharmacy",
      "question": "Will the medication be dispensed by a specialty pharmacy?",
      "context": "Checkbox indicating if the medication will be obtained from a specialty pharmacy."
    },
    {
      "name": "Provider Admin CB.25",
      "type": "checkbox",
      "page": 2,
      "field_label": "Mail Order",
      "question": "Will the medication be dispensed by mail order?",
      "context": "Checkbox indicating if the medication will be delivered via mail order pharmacy services."
    },
    {
      "name": "Provider Admin CB.26",
      "type": "checkbox",
      "page": 2,
      "field_label": "Other:",
      "question": "Will the medication be dispensed/administered by another type of facility not listed?",
      "context": "Option to specify an alternative dispensing or administration location not pre-listed."
    },
    {
      "name": "Provider Admin T.27",
      "type": "text",
      "page": 2,
      "field_label": "Other:",
      "question": "Please specify the 'Other' dispensing/administration location.",
      "context": "Text field to describe the specific 'other' dispensing/administration location if the checkbox is selected."
    },
    {
      "name": "Provider Admin T.28",
      "type": "text",
      "page": 2,
      "field_label": "Name:",
      "question": "What is the name of the dispensing provider/pharmacy?",
      "context": "Name of the entity responsible for dispensing the medication."
    },
    {
      "name": "Provider Admin T.29a",
      "type": "text",
      "page": 2,
      "field_label": "Address:",
      "question": "What is the address of the dispensing provider/pharmacy?",
      "context": "Street address of the dispensing provider or pharmacy."
    },
    {
      "name": "Provider Admin T.30a",
      "type": "text",
      "page": 2,
      "field_label": "City:",
      "question": "What is the city of the dispensing provider/pharmacy?",
      "context": "City of the dispensing provider or pharmacy."
    },
    {
      "name": "Provider Admin T.31",
      "type": "text",
      "page": 2,
      "field_label": "State:",
      "question": "What is the state of the dispensing provider/pharmacy?",
      "context": "State of the dispensing provider or pharmacy."
    },
    {
      "name": "Provider Admin T.32",
      "type": "text",
      "page": 2,
      "field_label": "ZIP:",
      "question": "What is the ZIP code of the dispensing provider/pharmacy?",
      "context": "ZIP code of the dispensing provider or pharmacy."
    },
    {
      "name": "Provider Admin T.33",
      "type": "text",
      "page": 2,
      "field_label": "Phone:",
      "question": "What is the phone number for the dispensing provider/pharmacy?",
      "context": "Contact phone number for the dispensing provider or pharmacy."
    },
    {
      "name": "Provider Admin T.34",
      "type": "text",
      "page": 2,
      "field_label": "Fax:",
      "question": "What is the fax number for the dispensing provider/pharmacy?",
      "context": "Fax number for the dispensing provider or pharmacy for document transmission."
    },
    {
      "name": "Provider Admin T.35",
      "type": "text",
      "page": 2,
      "field_label": "TIN:",
      "question": "What is the Tax Identification Number (TIN) for the dispensing provider/pharmacy?",
      "context": "TIN of the dispensing provider or pharmacy for tax and billing purposes."
    },
    {
      "name": "Provider Admin T.36",
      "type": "text",
      "page": 2,
      "field_label": "PIN:",
      "question": "What is the Provider Identification Number (PIN) for the dispensing provider/pharmacy?",
      "context": "PIN of the dispensing provider or pharmacy for unique identification."
    },
    {
      "name": "Provider Admin T.37",
      "type": "text",
      "page": 2,
      "field_label": "NPI:",
      "question": "What is the NPI (National Provider Identifier) for the dispensing provider/pharmacy?",
      "context": "NPI of the dispensing provider or pharmacy for standardized identification."
    },
    {
      "name": "CB60",
      "type": "checkbox",
      "page": 2,
      "field_label": "Riabni (rituximab-arrx)",
      "question": "Is the requested product Riabni (rituximab-arrx)?",
      "context": "Selection for Riabni, a non-preferred rituximab biosimilar, in the Product Information section."
    },
    {
      "name": "CB61",
      "type": "checkbox",
      "page": 2,
      "field_label": "Rituxan (rituximab)",
      "question": "Is the requested product Rituxan (rituximab)?",
      "context": "Selection for Rituxan, a non-preferred rituximab product, in the Product Information section."
    },
    {
      "name": "CB62",
      "type": "checkbox",
      "page": 2,
      "field_label": "Ruxience (rituximab-pvvr)",
      "question": "Is the requested product Ruxience (rituximab-pvvr)?",
      "context": "Selection for Ruxience, a preferred rituximab biosimilar, in the Product Information section."
    },
    {
      "name": "CB63",
      "type": "checkbox",
      "page": 2,
      "field_label": "Truxima (rituximab-abbs)",
      "question": "Is the requested product Truxima (rituximab-abbs)?",
      "context": "Selection for Truxima, a preferred rituximab biosimilar, in the Product Information section."
    },
    {
      "name": "T64",
      "type": "text",
      "page": 2,
      "field_label": "Dose:",
      "question": "What is the prescribed dose of the requested medication?",
      "context": "Prescribed dosage of the medication, essential for clinical review and safety."
    },
    {
      "name": "T65",
      "type": "text",
      "page": 2,
      "field_label": "Directions for Use:",
      "question": "What are the directions for use of the requested medication?",
      "context": "Instructions for medication administration, including frequency and route, for clinical assessment."
    },
    {
      "name": "T66",
      "type": "text",
      "page": 2,
      "field_label": "HCPCS Code:",
      "question": "What is the HCPCS code for the requested medication or service?",
      "context": "HCPCS code identifying the specific drug or service for billing and coverage determination."
    },
    {
      "name": "T67",
      "type": "text",
      "page": 2,
      "field_label": "Primary ICD Code:",
      "question": "What is the primary ICD code for the patient's diagnosis?",
      "context": "Primary International Classification of Diseases (ICD) code describing the patient's main diagnosis."
    },
    {
      "name": "CB68",
      "type": "checkbox",
      "page": 2,
      "field_label": "Other ICD Code:",
      "question": "Are there other ICD codes applicable to the patient's diagnosis?",
      "context": "Checkbox indicating if additional ICD codes will be provided for other relevant diagnoses."
    },
    {
      "name": "T69",
      "type": "text",
      "page": 2,
      "field_label": "Other ICD Code:",
      "question": "What are the other applicable ICD codes?",
      "context": "Lists additional ICD codes for co-morbidities or secondary diagnoses, if applicable."
    },
    {
      "name": "CB70",
      "type": "checkbox",
      "page": 2,
      "field_label": "Yes",
      "question": "Has the patient received prior therapy with the requested product within the last 365 days?",
      "context": "Indicates if the patient has recent experience with the specific medication being requested."
    },
    {
      "name": "CB71",
      "type": "checkbox",
      "page": 2,
      "field_label": "No",
      "question": "Has the patient not received prior therapy with the requested product within the last 365 days?",
      "context": "Indicates if the patient has no recent history of therapy with the requested medication."
    },
    {
      "name": "CB72",
      "type": "checkbox",
      "page": 2,
      "field_label": "No",
      "question": "Has the patient NOT had a trial and failure of any rituximab biosimilars listed?",
      "context": "Indicates if the patient has not failed preferred rituximab biosimilars, influencing product selection."
    },
    {
      "name": "CB73",
      "type": "checkbox",
      "page": 2,
      "field_label": "Ruxience (rituximab-pvvr)",
      "question": "Has the patient had a trial and failure of Ruxience (rituximab-pvvr)?",
      "context": "Indicates if the patient has failed a trial of the preferred rituximab biosimilar Ruxience."
    },
    {
      "name": "CB74",
      "type": "checkbox",
      "page": 2,
      "field_label": "Truxima (rituximab-abbs)",
      "question": "Has the patient had a trial and failure of Truxima (rituximab-abbs)?",
      "context": "Indicates if the patient has failed a trial of the preferred rituximab biosimilar Truxima."
    },
    {
      "name": "T75",
      "type": "text",
      "page": 2,
      "field_label": "When was the member’s trial and failure of the preferred drug?",
      "question": "When did the patient's trial and failure of the preferred drug occur?",
      "context": "Date of documented trial failure of preferred biosimilars, supporting the current request."
    },
    {
      "name": "T76",
      "type": "text",
      "page": 2,
      "field_label": "Please describe the nature of the failure of the preferred drug",
      "question": "What was the nature of the patient's failure with the preferred drug?",
      "context": "Detailed explanation of why the preferred medication failed, for medical necessity review."
    },
    {
      "name": "CB77",
      "type": "checkbox",
      "page": 2,
      "field_label": "No",
      "question": "Has the patient NOT had an adverse reaction to any rituximab biosimilars listed?",
      "context": "Indicates if the patient has not experienced adverse reactions to preferred rituximab biosimilars."
    },
    {
      "name": "CB78",
      "type": "checkbox",
      "page": 2,
      "field_label": "Ruxience (rituximab-pvvr)",
      "question": "Has the patient had an adverse reaction to Ruxience (rituximab-pvvr)?",
      "context": "Indicates if the patient experienced an adverse reaction to the preferred biosimilar Ruxience."
    },
    {
      "name": "CB79",
      "type": "checkbox",
      "page": 2,
      "field_label": "Truxima (rituximab-abbs)",
      "question": "Has the patient had an adverse reaction to Truxima (rituximab-abbs)?",
      "context": "Indicates if the patient experienced an adverse reaction to the preferred biosimilar Truxima."
    },
    {
      "name": "T80",
      "type": "text",
      "page": 2,
      "field_label": "When was the member’s adverse reaction to the preferred drug?",
      "question": "When did the patient's adverse reaction to the preferred drug occur?",
      "context": "Date of documented adverse reaction to preferred biosimilars, supporting current request."
    },
    {
      "name": "T81",
      "type": "text",
      "page": 2,
      "field_label": "Please describe the nature of the adverse reaction to the preferred drug",
      "question": "What was the nature of the patient's adverse reaction to the preferred drug?",
      "context": "Detailed explanation of the adverse reaction to the preferred medication, for medical necessity."
    },
    {
      "name": "T84",
      "type": "text",
      "page": 2,
      "field_label": "Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred biosimilar products when indicated for the patient’s diagnosis?",
      "question": "Please explain any contraindications or medical reasons preventing the patient from using preferred rituximab biosimilars.",
      "context": "Requires a clinical justification for not using preferred biosimilar rituximab options, if applicable."
    },
    {
      "name": "CB82",
      "type": "checkbox",
      "page": 2,
      "field_label": "Ruxience (rituximab-pvvr)",
      "question": "Is Ruxience (rituximab-pvvr) contraindicated or medically unsuitable for the patient's diagnosis?",
      "context": "Indicates a contraindication or medical reason preventing the use of Ruxience for the patient."
    },
    {
      "name": "CB83",
      "type": "checkbox",
      "page": 2,
      "field_label": "Truxima (rituximab-abbs)",
      "question": "Is Truxima (rituximab-abbs) contraindicated or medically unsuitable for the patient's diagnosis?",
      "context": "Indicates a contraindication or medical reason preventing the use of Truxima for the patient."
    }
  ],
  "3": [
    {
      "name": "T12",
      "type": "text",
      "page": 3,
      "field_label": "Patient First Name",
      "question": "What is the patient's first name?",
      "context": "Patient's given name, essential for identification in the clinical information section."
    },
    {
      "name": "T13",
      "type": "text",
      "page": 3,
      "field_label": "Patient Last Name",
      "question": "What is the patient's last name?",
      "context": "Patient's surname, crucial for accurate identification within the clinical data."
    },
    {
      "name": "T19",
      "type": "text",
      "page": 3,
      "field_label": "Patient Phone",
      "question": "What is the patient's phone number?",
      "context": "Patient's contact phone number for communication regarding clinical information or requests."
    },
    {
      "name": "T14",
      "type": "text",
      "page": 3,
      "field_label": "Patient DOB (MM/DD/YYYY)",
      "question": "What is the patient's date of birth?",
      "context": "Patient's date of birth in MM/DD/YYYY format for age verification and patient matching."
    },
    {
      "name": "CB86",
      "type": "checkbox",
      "page": 3,
      "field_label": "Inflectra (infliximab-dyyb)",
      "question": "Has the patient had a trial and failure of Inflectra (infliximab-dyyb)?",
      "context": "Indicates if Inflectra, a preferred biosimilar, was tried and failed as prior therapy."
    },
    {
      "name": "CB87",
      "type": "checkbox",
      "page": 3,
      "field_label": "Renflexis (infliximab-abda)",
      "question": "Has the patient had a trial and failure of Renflexis (infliximab-abda)?",
      "context": "Indicates if Renflexis, a preferred biosimilar, was tried and failed as prior therapy."
    },
    {
      "name": "CB88",
      "type": "checkbox",
      "page": 3,
      "field_label": "Simponi Aria (golimumab)",
      "question": "Has the patient had a trial and failure of Simponi Aria (golimumab)?",
      "context": "Indicates if Simponi Aria, a preferred biologic, was tried and failed as prior therapy."
    },
    {
      "name": "T89",
      "type": "text",
      "page": 3,
      "field_label": "When was the member’s trial and failure of the preferred drug?",
      "question": "When did the patient experience trial and failure of the preferred drug?",
      "context": "Date of trial and failure for the previously selected preferred biosimilar or biologic."
    },
    {
      "name": "T90",
      "type": "text",
      "page": 3,
      "field_label": "Please describe the nature of the failure of the preferred drug",
      "question": "Please describe how the preferred drug trial failed.",
      "context": "Detailed explanation of clinical reasons for failure of prior preferred therapy."
    },
    {
      "name": "CB85",
      "type": "checkbox",
      "page": 3,
      "field_label": "No",
      "question": "Has the patient NOT had a trial and failure of Inflectra, Renflexis, or Simponi Aria?",
      "context": "Indicates no prior trial and failure of listed preferred therapies for patient. Dependent on parent question."
    },
    {
      "name": "CB92",
      "type": "checkbox",
      "page": 3,
      "field_label": "Inflectra (infliximab-dyyb)",
      "question": "Has the patient had an adverse reaction to Inflectra (infliximab-dyyb)?",
      "context": "Indicates if Inflectra, a preferred biosimilar, caused an adverse reaction for patient."
    },
    {
      "name": "CB93",
      "type": "checkbox",
      "page": 3,
      "field_label": "Renflexis (infliximab-abda)",
      "question": "Has the patient had an adverse reaction to Renflexis (infliximab-abda)?",
      "context": "Indicates if Renflexis, a preferred biosimilar, caused an adverse reaction for patient."
    },
    {
      "name": "CB94",
      "type": "checkbox",
      "page": 3,
      "field_label": "Simponi Aria (golimumab)",
      "question": "Has the patient had an adverse reaction to Simponi Aria (golimumab)?",
      "context": "Indicates if Simponi Aria, a preferred biologic, caused an adverse reaction for patient."
    },
    {
      "name": "T95",
      "type": "text",
      "page": 3,
      "field_label": "When was the member’s adverse reaction to the preferred drug?",
      "question": "When did the patient experience an adverse reaction to the preferred drug?",
      "context": "Date of adverse reaction to the previously selected preferred biosimilar or biologic."
    },
    {
      "name": "T96a",
      "type": "text",
      "page": 3,
      "field_label": "Please describe the nature of the adverse reaction to the preferred drug",
      "question": "Please describe the adverse reaction to the preferred drug.",
      "context": "Detailed explanation of the adverse event encountered with prior preferred therapy."
    },
    {
      "name": "CB91",
      "type": "checkbox",
      "page": 3,
      "field_label": "No",
      "question": "Has the patient NOT had an adverse reaction to Inflectra, Renflexis, or Simponi Aria?",
      "context": "Indicates no prior adverse reaction to listed preferred therapies for patient. Dependent on parent question."
    },
    {
      "name": "CB98a",
      "type": "checkbox",
      "page": 3,
      "field_label": "Enbrel (etanercept)",
      "question": "Has the patient had a trial and failure of Enbrel (etanercept)?",
      "context": "Indicates if Enbrel, a preferred MA plan therapy, was tried and failed as prior therapy."
    },
    {
      "name": "CB99a",
      "type": "checkbox",
      "page": 3,
      "field_label": "Humira (adalimumab)",
      "question": "Has the patient had a trial and failure of Humira (adalimumab)?",
      "context": "Indicates if Humira, a preferred MA plan therapy, was tried and failed as prior therapy."
    },
    {
      "name": "CB100a",
      "type": "checkbox",
      "page": 3,
      "field_label": "Idacio (adalimumab-aacf)",
      "question": "Has the patient had a trial and failure of Idacio (adalimumab-aacf)?",
      "context": "Indicates if Idacio, a preferred MA plan therapy, was tried and failed as prior therapy."
    },
    {
      "name": "CB101a",
      "type": "checkbox",
      "page": 3,
      "field_label": "Rinvoq (upadacitinib)",
      "question": "Has the patient had a trial and failure of Rinvoq (upadacitinib)?",
      "context": "Indicates if Rinvoq, a preferred MA plan therapy, was tried and failed as prior therapy."
    },
    {
      "name": "CB102a",
      "type": "checkbox",
      "page": 3,
      "field_label": "Tyenne SC (tocilizumab-aazg)",
      "question": "Has the patient had a trial and failure of Tyenne SC (tocilizumab-aazg)?",
      "context": "Indicates if Tyenne SC, a preferred MA plan therapy, was tried and failed as prior therapy."
    },
    {
      "name": "CB103a",
      "type": "checkbox",
      "page": 3,
      "field_label": "Xeljanz/Xeljanz XR (tofacitinib)",
      "question": "Has the patient had a trial and failure of Xeljanz/Xeljanz XR (tofacitinib)?",
      "context": "Indicates if Xeljanz/Xeljanz XR, a preferred MA plan therapy, was tried and failed as prior therapy."
    },
    {
      "name": "T104",
      "type": "text",
      "page": 3,
      "field_label": "When was the member’s trial and failure of the preferred drug?",
      "question": "When did the patient experience trial and failure of the preferred drug?",
      "context": "Date of trial and failure for the previously selected preferred MA plan drug."
    },
    {
      "name": "T105",
      "type": "text",
      "page": 3,
      "field_label": "Please describe the nature of the failure of the preferred drug",
      "question": "Please describe how the preferred drug trial failed.",
      "context": "Detailed explanation of clinical reasons for failure of prior preferred MA plan therapy."
    },
    {
      "name": "CB97",
      "type": "checkbox",
      "page": 3,
      "field_label": "No",
      "question": "Has the patient NOT had a trial and failure of any listed preferred MA plan drug?",
      "context": "Indicates no prior trial and failure of listed preferred MA plan therapies for patient. Dependent on parent question."
    },
    {
      "name": "CB107z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Enbrel (etanercept)",
      "question": "Has the patient had an adverse reaction to Enbrel (etanercept)?",
      "context": "Indicates if Enbrel, a preferred MA plan therapy, caused an adverse reaction for patient."
    },
    {
      "name": "CB108z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Humira (adalimumab)",
      "question": "Has the patient had an adverse reaction to Humira (adalimumab)?",
      "context": "Indicates if Humira, a preferred MA plan therapy, caused an adverse reaction for patient."
    },
    {
      "name": "CB109z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Idacio (adalimumab-aacf)",
      "question": "Has the patient had an adverse reaction to Idacio (adalimumab-aacf)?",
      "context": "Indicates if Idacio, a preferred MA plan therapy, caused an adverse reaction for patient."
    },
    {
      "name": "CB110z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Rinvoq (upadacitinib)",
      "question": "Has the patient had an adverse reaction to Rinvoq (upadacitinib)?",
      "context": "Indicates if Rinvoq, a preferred MA plan therapy, caused an adverse reaction for patient."
    },
    {
      "name": "CB111z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Tyenne SC (tocilizumab-aazg)",
      "question": "Has the patient had an adverse reaction to Tyenne SC (tocilizumab-aazg)?",
      "context": "Indicates if Tyenne SC, a preferred MA plan therapy, caused an adverse reaction for patient."
    },
    {
      "name": "CB112z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Xeljanz/Xeljanz XR (tofacitinib)",
      "question": "Has the patient had an adverse reaction to Xeljanz/Xeljanz XR (tofacitinib)?",
      "context": "Indicates if Xeljanz/Xeljanz XR, a preferred MA plan therapy, caused an adverse reaction for patient."
    },
    {
      "name": "T113",
      "type": "text",
      "page": 3,
      "field_label": "When was the member’s adverse reaction to the preferred drug?",
      "question": "When did the patient experience an adverse reaction to the preferred drug?",
      "context": "Date of adverse reaction to the previously selected preferred MA plan drug."
    },
    {
      "name": "T114",
      "type": "text",
      "page": 3,
      "field_label": "Please describe the nature of the adverse reaction to the preferred drug",
      "question": "Please describe the adverse reaction to the preferred drug.",
      "context": "Detailed explanation of the adverse event encountered with prior preferred MA plan therapy."
    },
    {
      "name": "CB106z",
      "type": "checkbox",
      "page": 3,
      "field_label": "No",
      "question": "Has the patient NOT had an adverse reaction to any listed preferred MA plan drug?",
      "context": "Indicates no prior adverse reaction to listed preferred MA plan therapies for patient. Dependent on parent question."
    },
    {
      "name": "T118",
      "type": "text",
      "page": 3,
      "field_label": "Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient’s diagnosis?",
      "question": "Please explain contraindications or other medical reasons preventing the patient from using the preferred biosimilars (Inflectra, Renflexis, Simponi Aria) for the diagnosis.",
      "context": "Explanation for not using preferred infliximab biosimilars/biologic due to contraindications or other medical reasons."
    },
    {
      "name": "CB115z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Inflectra (infliximab-dyyb)",
      "question": "Is Inflectra (infliximab-dyyb) contraindicated for this patient's diagnosis?",
      "context": "Indicates if Inflectra is contraindicated for the patient's specific diagnosis."
    },
    {
      "name": "CB116z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Renflexis (infliximab-abda)",
      "question": "Is Renflexis (infliximab-abda) contraindicated for this patient's diagnosis?",
      "context": "Indicates if Renflexis is contraindicated for the patient's specific diagnosis."
    },
    {
      "name": "CB117z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Simponi Aria (golimumab)",
      "question": "Is Simponi Aria (golimumab) contraindicated for this patient's diagnosis?",
      "context": "Indicates if Simponi Aria is contraindicated for the patient's specific diagnosis."
    },
    {
      "name": "T125",
      "type": "text",
      "page": 3,
      "field_label": "Please explain if there are contraindications or any other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient’s diagnosis?",
      "question": "Please explain contraindications or other medical reasons preventing the patient from using the preferred MA plan drugs (Enbrel, Humira, Idacio, Rinvoq, Tyenne SC, Xeljanz/Xeljanz XR) for the diagnosis.",
      "context": "Explanation for not using preferred MA plan drugs due to contraindications or other medical reasons for patient's diagnosis."
    },
    {
      "name": "CB119z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Enbrel (etanercept)",
      "question": "Is Enbrel (etanercept) contraindicated for this patient's diagnosis?",
      "context": "Indicates if Enbrel is contraindicated for the patient's specific diagnosis."
    },
    {
      "name": "CB120z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Humira (adalimumab)",
      "question": "Is Humira (adalimumab) contraindicated for this patient's diagnosis?",
      "context": "Indicates if Humira is contraindicated for the patient's specific diagnosis."
    },
    {
      "name": "CB121z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Idacio (adalimumab-aacf)",
      "question": "Is Idacio (adalimumab-aacf) contraindicated for this patient's diagnosis?",
      "context": "Indicates if Idacio is contraindicated for the patient's specific diagnosis."
    },
    {
      "name": "CB122z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Rinvoq (upadacitinib)",
      "question": "Is Rinvoq (upadacitinib) contraindicated for this patient's diagnosis?",
      "context": "Indicates if Rinvoq is contraindicated for the patient's specific diagnosis."
    },
    {
      "name": "CB123z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Tyenne SC (tocilizumab-aazg)",
      "question": "Is Tyenne SC (tocilizumab-aazg) contraindicated for this patient's diagnosis?",
      "context": "Indicates if Tyenne SC is contraindicated for the patient's specific diagnosis."
    },
    {
      "name": "CB124z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Xeljanz/Xeljanz XR (tofacitinib)",
      "question": "Is Xeljanz/Xeljanz XR (tofacitinib) contraindicated for this patient's diagnosis?",
      "context": "Indicates if Xeljanz/Xeljanz XR is contraindicated for the patient's specific diagnosis."
    },
    {
      "name": "CB96.4.0",
      "type": "checkbox",
      "page": 3,
      "field_label": "Yes",
      "question": "Will Rituxan be used concomitantly with apremilast, tofacitinib, or other biologic DMARDs?",
      "context": "Indicates if Rituxan will be co-administered with other DMARDs, relevant for drug interaction assessment."
    },
    {
      "name": "CB98",
      "type": "checkbox",
      "page": 3,
      "field_label": "No",
      "question": "Will Rituxan NOT be used concomitantly with apremilast, tofacitinib, or other biologic DMARDs?",
      "context": "Indicates no co-administration of Rituxan with other DMARDs, relevant for drug interaction assessment."
    },
    {
      "name": "CB99.0",
      "type": "checkbox",
      "page": 3,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)?",
      "context": "Confirms patient's diagnosis of specific acute lymphoid leukemia subtype."
    },
    {
      "name": "CB100.0",
      "type": "checkbox",
      "page": 3,
      "field_label": "No",
      "question": "Does the patient NOT have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)?",
      "context": "Denies specific acute lymphoid leukemia diagnosis for the patient."
    },
    {
      "name": "CB101.0",
      "type": "checkbox",
      "page": 3,
      "field_label": "Yes",
      "question": "Is Rituxan (rituximab) being used as induction/consolidation therapy for ALL?",
      "context": "Confirms Rituxan's role as induction/consolidation therapy for acute lymphoid leukemia."
    },
    {
      "name": "CB102.0",
      "type": "checkbox",
      "page": 3,
      "field_label": "No",
      "question": "Is Rituxan (rituximab) NOT being used as induction/consolidation therapy for ALL?",
      "context": "Denies Rituxan's role as induction/consolidation therapy for acute lymphoid leukemia."
    },
    {
      "name": "CB103",
      "type": "checkbox",
      "page": 3,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of refractory autoimmune hemolytic anemia?",
      "context": "Confirms patient's diagnosis of autoimmune hemolytic anemia refractory to other treatments."
    },
    {
      "name": "CB104",
      "type": "checkbox",
      "page": 3,
      "field_label": "No",
      "question": "Does the patient NOT have a documented diagnosis of refractory autoimmune hemolytic anemia?",
      "context": "Denies refractory autoimmune hemolytic anemia diagnosis for the patient."
    },
    {
      "name": "CB104a",
      "type": "checkbox",
      "page": 3,
      "field_label": "Wegener granulomatosis",
      "question": "Does the patient have Wegener granulomatosis?",
      "context": "Identifies Wegener granulomatosis as the specific ANCA-associated vasculitis diagnosis."
    },
    {
      "name": "CB104b",
      "type": "checkbox",
      "page": 3,
      "field_label": "Churg-Strauss syndrome",
      "question": "Does the patient have Churg-Strauss syndrome?",
      "context": "Identifies Churg-Strauss syndrome as the specific ANCA-associated vasculitis diagnosis."
    },
    {
      "name": "CB104c",
      "type": "checkbox",
      "page": 3,
      "field_label": "microscopic polyangiitis",
      "question": "Does the patient have microscopic polyangiitis?",
      "context": "Identifies microscopic polyangiitis as the specific ANCA-associated vasculitis diagnosis."
    },
    {
      "name": "CB104d",
      "type": "checkbox",
      "page": 3,
      "field_label": "pauci-immune glomerulonephritis",
      "question": "Does the patient have pauci-immune glomerulonephritis?",
      "context": "Identifies pauci-immune glomerulonephritis as the specific ANCA-associated vasculitis diagnosis."
    },
    {
      "name": "CB105",
      "type": "checkbox",
      "page": 3,
      "field_label": "Yes",
      "question": "Will Rituxan (rituximab) be given in conjunction with glucocorticoids?",
      "context": "Indicates if Rituxan will be co-administered with glucocorticoids for ANCA-associated vasculitides treatment."
    },
    {
      "name": "CB106",
      "type": "checkbox",
      "page": 3,
      "field_label": "No",
      "question": "Will Rituxan (rituximab) NOT be given in conjunction with glucocorticoids?",
      "context": "Indicates no co-administration of Rituxan with glucocorticoids for ANCA-associated vasculitides treatment."
    },
    {
      "name": "CB106a",
      "type": "checkbox",
      "page": 3,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease?",
      "context": "Confirms patient's diagnosis of autoimmune blistering disease refractory to corticosteroids."
    },
    {
      "name": "CB107",
      "type": "checkbox",
      "page": 3,
      "field_label": "pemphigus vulgaris",
      "question": "Does the patient have pemphigus vulgaris?",
      "context": "Identifies pemphigus vulgaris as the specific autoimmune blistering disease diagnosis."
    },
    {
      "name": "CB108",
      "type": "checkbox",
      "page": 3,
      "field_label": "pemphigus folliaceus",
      "question": "Does the patient have pemphigus folliaceus?",
      "context": "Identifies pemphigus folliaceus as the specific autoimmune blistering disease diagnosis."
    },
    {
      "name": "CB109",
      "type": "checkbox",
      "page": 3,
      "field_label": "bullous pemphigoid",
      "question": "Does the patient have bullous pemphigoid?",
      "context": "Identifies bullous pemphigoid as the specific autoimmune blistering disease diagnosis."
    },
    {
      "name": "CB110",
      "type": "checkbox",
      "page": 3,
      "field_label": "cicatricial pemphigoid",
      "question": "Does the patient have cicatricial pemphigoid?",
      "context": "Identifies cicatricial pemphigoid as the specific autoimmune blistering disease diagnosis."
    },
    {
      "name": "CB111",
      "type": "checkbox",
      "page": 3,
      "field_label": "epidermolysis bullosa acquisita",
      "question": "Does the patient have epidermolysis bullosa acquisita?",
      "context": "Identifies epidermolysis bullosa acquisita as the specific autoimmune blistering disease diagnosis."
    },
    {
      "name": "CB112",
      "type": "checkbox",
      "page": 3,
      "field_label": "paraneoplastic pemphigus",
      "question": "Does the patient have paraneoplastic pemphigus?",
      "context": "Identifies paraneoplastic pemphigus as the specific autoimmune blistering disease diagnosis."
    },
    {
      "name": "CB113",
      "type": "checkbox",
      "page": 3,
      "field_label": "None of the above",
      "question": "Is the patient's autoimmune blistering disease NOT among the listed options?",
      "context": "Indicates if the patient's specific autoimmune blistering disease diagnosis is not provided in the list."
    },
    {
      "name": "CB106b",
      "type": "checkbox",
      "page": 3,
      "field_label": "No",
      "question": "Does the patient NOT have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease?",
      "context": "Denies corticosteroid-refractory autoimmune blistering disease diagnosis for the patient."
    },
    {
      "name": "CB114",
      "type": "checkbox",
      "page": 3,
      "field_label": "AIDS-related B-cell lymphoma",
      "question": "Does the patient have AIDS-related B-cell lymphoma?",
      "context": "Identifies AIDS-related B-cell lymphoma as the specific B-cell lymphoma diagnosis."
    },
    {
      "name": "CB115",
      "type": "checkbox",
      "page": 3,
      "field_label": "Burkitt lymphoma",
      "question": "Does the patient have Burkitt lymphoma?",
      "context": "Identifies Burkitt lymphoma as the specific B-cell lymphoma diagnosis."
    },
    {
      "name": "CB116",
      "type": "checkbox",
      "page": 3,
      "field_label": "Diffuse large B-cell lymphoma",
      "question": "Does the patient have Diffuse large B-cell lymphoma?",
      "context": "Identifies diffuse large B-cell lymphoma as the specific B-cell lymphoma diagnosis."
    },
    {
      "name": "CB117",
      "type": "checkbox",
      "page": 3,
      "field_label": "Follicular lymphoma",
      "question": "Does the patient have Follicular lymphoma?",
      "context": "Identifies follicular lymphoma as the specific B-cell lymphoma diagnosis."
    },
    {
      "name": "CB118",
      "type": "checkbox",
      "page": 3,
      "field_label": "Gastric MALT lymphoma",
      "question": "Does the patient have Gastric MALT lymphoma?",
      "context": "Identifies gastric MALT lymphoma as the specific B-cell lymphoma diagnosis."
    },
    {
      "name": "CB119",
      "type": "checkbox",
      "page": 3,
      "field_label": "High-grade B-Cell lymphoma",
      "question": "Does the patient have High-grade B-Cell lymphoma?",
      "context": "Identifies high-grade B-Cell lymphoma as the specific B-cell lymphoma diagnosis."
    },
    {
      "name": "CB120",
      "type": "checkbox",
      "page": 3,
      "field_label": "Mantle cell lymphoma",
      "question": "Does the patient have Mantle cell lymphoma?",
      "context": "Identifies mantle cell lymphoma as the specific B-cell lymphoma diagnosis."
    },
    {
      "name": "CB121",
      "type": "checkbox",
      "page": 3,
      "field_label": "Nodal marginal zone lymphoma",
      "question": "Does the patient have Nodal marginal zone lymphoma?",
      "context": "Identifies nodal marginal zone lymphoma as the specific B-cell lymphoma diagnosis."
    },
    {
      "name": "CB122",
      "type": "checkbox",
      "page": 3,
      "field_label": "Nongastric MALT lymphoma",
      "question": "Does the patient have Nongastric MALT lymphoma?",
      "context": "Identifies nongastric MALT lymphoma as the specific B-cell lymphoma diagnosis."
    },
    {
      "name": "CB123",
      "type": "checkbox",
      "page": 3,
      "field_label": "Primary cutaneous B-cell lymphomas",
      "question": "Does the patient have Primary cutaneous B-cell lymphomas?",
      "context": "Identifies primary cutaneous B-cell lymphomas as the specific B-cell lymphoma diagnosis."
    },
    {
      "name": "CB124",
      "type": "checkbox",
      "page": 3,
      "field_label": "Splenic marginal zone lymphoma",
      "question": "Does the patient have Splenic marginal zone lymphoma?",
      "context": "Identifies splenic marginal zone lymphoma as the specific B-cell lymphoma diagnosis."
    },
    {
      "name": "CB125",
      "type": "checkbox",
      "page": 3,
      "field_label": "Other:",
      "question": "Does the patient have an 'Other' type of B-cell lymphoma not listed?",
      "context": "Indicates if the patient's B-cell lymphoma diagnosis falls outside the provided categories."
    },
    {
      "name": "T126",
      "type": "text",
      "page": 3,
      "field_label": "Other:",
      "question": "Please specify the other type of B-cell lymphoma.",
      "context": "Text field to specify a B-cell lymphoma diagnosis not found in the predefined list."
    }
  ],
  "4": [
    {
      "name": "T12",
      "type": "text",
      "page": 4,
      "field_label": "Patient First Name",
      "question": "What is the patient's first name?",
      "context": "Patient's demographic information, required for identification and linking to medical records."
    },
    {
      "name": "T13",
      "type": "text",
      "page": 4,
      "field_label": "Patient Last Name",
      "question": "What is the patient's last name?",
      "context": "Patient's demographic information, required for identification and linking to medical records."
    },
    {
      "name": "T19",
      "type": "text",
      "page": 4,
      "field_label": "Patient Phone",
      "question": "What is the patient's phone number?",
      "context": "Patient's contact information for communication regarding the prior authorization request."
    },
    {
      "name": "T14",
      "type": "text",
      "page": 4,
      "field_label": "Patient DOB (MM/DD/YYYY)",
      "question": "What is the patient's date of birth?",
      "context": "Patient's demographic information, essential for accurate identification and age verification."
    },
    {
      "name": "CB127",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of multicentric Castleman's disease?",
      "context": "Primary question for Castleman's disease, confirming patient's diagnosis for treatment eligibility."
    },
    {
      "name": "CB128",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Does the patient NOT have a documented diagnosis of multicentric Castleman's disease?",
      "context": "Primary question for Castleman's disease, confirming patient's diagnosis for treatment eligibility."
    },
    {
      "name": "CB129",
      "type": "checkbox",
      "page": 4,
      "field_label": "leptomeningeal metastases from lymphoma",
      "question": "Does the patient's central nervous system lymphoma involve leptomeningeal metastases?",
      "context": "Sub-question for Central Nervous System Lymphomas, specifying disease manifestation for treatment protocol."
    },
    {
      "name": "CB130",
      "type": "checkbox",
      "page": 4,
      "field_label": "primary CNS lymphoma",
      "question": "Does the patient have primary CNS lymphoma?",
      "context": "Sub-question for Central Nervous System Lymphomas, identifying the specific type of lymphoma."
    },
    {
      "name": "CB131",
      "type": "checkbox",
      "page": 4,
      "field_label": "none of the above",
      "question": "Are none of the above central nervous system lymphoma types applicable to the patient?",
      "context": "Sub-question for Central Nervous System Lymphomas, indicating if patient's condition falls outside specified types."
    },
    {
      "name": "CB132",
      "type": "checkbox",
      "page": 4,
      "field_label": "chronic lymphocytic leukemia (CLL)",
      "question": "Does the patient have chronic lymphocytic leukemia (CLL)?",
      "context": "Sub-question for Chronic or Small Lymphocytic Leukemia, specifying the leukemia type for treatment."
    },
    {
      "name": "CB133",
      "type": "checkbox",
      "page": 4,
      "field_label": "small lymphocytic leukemia",
      "question": "Does the patient have small lymphocytic leukemia?",
      "context": "Sub-question for Chronic or Small Lymphocytic Leukemia, specifying the leukemia type for treatment."
    },
    {
      "name": "CB134",
      "type": "checkbox",
      "page": 4,
      "field_label": "none of the above",
      "question": "Are none of the above chronic or small lymphocytic leukemia types applicable to the patient?",
      "context": "Sub-question for Chronic or Small Lymphocytic Leukemia, indicating if patient's condition falls outside specified types."
    },
    {
      "name": "CB135",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of cryoglobulinemia?",
      "context": "Primary question for Cryoglobulinemia, confirming the patient's diagnosis for treatment eligibility."
    },
    {
      "name": "CB136",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Does the patient NOT have a documented diagnosis of cryoglobulinemia?",
      "context": "Primary question for Cryoglobulinemia, confirming the patient's diagnosis for treatment eligibility."
    },
    {
      "name": "CB139",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Is there clinical documentation that corticosteroids and other immunosuppressive agents were ineffective for cryoglobulinemia?",
      "context": "Follow-up question for Cryoglobulinemia, assessing prior treatment failure with conventional therapies."
    },
    {
      "name": "CB140",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Is there NO clinical documentation that corticosteroids and other immunosuppressive agents were ineffective for cryoglobulinemia?",
      "context": "Follow-up question for Cryoglobulinemia, assessing prior treatment failure with conventional therapies."
    },
    {
      "name": "CB144",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Is there documentation that Rituxan (rituximab) is being used as a last-resort treatment for chronic graft versus host disease (GVHD)?",
      "context": "Primary question for Chronic Graft Versus Host Disease, verifying Rituxan's role as a salvage therapy."
    },
    {
      "name": "CB145",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Is there NO documentation that Rituxan (rituximab) is being used as a last-resort treatment for chronic graft versus host disease (GVHD)?",
      "context": "Primary question for Chronic Graft Versus Host Disease, verifying Rituxan's role as a salvage therapy."
    },
    {
      "name": "CB141",
      "type": "checkbox",
      "page": 4,
      "field_label": "relapsed hairy cell leukemia",
      "question": "Does the patient have relapsed hairy cell leukemia?",
      "context": "Sub-question for Hairy Cell Leukemia, specifying if the disease has recurred after initial treatment."
    },
    {
      "name": "CB142",
      "type": "checkbox",
      "page": 4,
      "field_label": "refractory hairy cell leukemia",
      "question": "Does the patient have refractory hairy cell leukemia?",
      "context": "Sub-question for Hairy Cell Leukemia, indicating if the disease is unresponsive to prior treatments."
    },
    {
      "name": "CB143",
      "type": "checkbox",
      "page": 4,
      "field_label": "none of the above",
      "question": "Are none of the above hairy cell leukemia types applicable to the patient?",
      "context": "Sub-question for Hairy Cell Leukemia, indicating if patient's condition falls outside specified types."
    },
    {
      "name": "CB137",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Is there documentation that Rituxan (rituximab) is being used for treatment or prevention of antibody-mediated rejection in heart or other solid organ transplant recipients?",
      "context": "Primary question for Heart and Solid Organ Transplant, confirming Rituxan's use for rejection management."
    },
    {
      "name": "CB146",
      "type": "checkbox",
      "page": 4,
      "field_label": "heart transplant recipient",
      "question": "Is the patient a heart transplant recipient?",
      "context": "Sub-question for Heart and Solid Organ Transplant, specifying the type of organ transplant received by the patient."
    },
    {
      "name": "CB147",
      "type": "checkbox",
      "page": 4,
      "field_label": "other solid organ transplant recipient",
      "question": "Is the patient an other solid organ transplant recipient?",
      "context": "Sub-question for Heart and Solid Organ Transplant, specifying the type of organ transplant received by the patient."
    },
    {
      "name": "CB138",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Is there NO documentation that Rituxan (rituximab) is being used for treatment or prevention of antibody-mediated rejection in heart or other solid organ transplant recipients?",
      "context": "Primary question for Heart and Solid Organ Transplant, confirming Rituxan's use for rejection management."
    },
    {
      "name": "CB148",
      "type": "checkbox",
      "page": 4,
      "field_label": "Bavencio (avelumab)",
      "question": "Did Bavencio (avelumab) cause the immune checkpoint-inhibitor related encephalitis?",
      "context": "Sub-question for Immune Checkpoint-Inhibitor Related Encephalitis, identifying the causative agent for diagnosis."
    },
    {
      "name": "CB149",
      "type": "checkbox",
      "page": 4,
      "field_label": "Imfinzi (durvalumab)",
      "question": "Did Imfinzi (durvalumab) cause the immune checkpoint-inhibitor related encephalitis?",
      "context": "Sub-question for Immune Checkpoint-Inhibitor Related Encephalitis, identifying the causative agent for diagnosis."
    },
    {
      "name": "CB150",
      "type": "checkbox",
      "page": 4,
      "field_label": "Keytruda (pembrolizumab)",
      "question": "Did Keytruda (pembrolizumab) cause the immune checkpoint-inhibitor related encephalitis?",
      "context": "Sub-question for Immune Checkpoint-Inhibitor Related Encephalitis, identifying the causative agent for diagnosis."
    },
    {
      "name": "CB151",
      "type": "checkbox",
      "page": 4,
      "field_label": "Opdivo (nivolumab)",
      "question": "Did Opdivo (nivolumab) cause the immune checkpoint-inhibitor related encephalitis?",
      "context": "Sub-question for Immune Checkpoint-Inhibitor Related Encephalitis, identifying the causative agent for diagnosis."
    },
    {
      "name": "CB152",
      "type": "checkbox",
      "page": 4,
      "field_label": "Tecentriq (atezolizumab)",
      "question": "Did Tecentriq (atezolizumab) cause the immune checkpoint-inhibitor related encephalitis?",
      "context": "Sub-question for Immune Checkpoint-Inhibitor Related Encephalitis, identifying the causative agent for diagnosis."
    },
    {
      "name": "CB153",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yervoy (ipilimumab)",
      "question": "Did Yervoy (ipilimumab) cause the immune checkpoint-inhibitor related encephalitis?",
      "context": "Sub-question for Immune Checkpoint-Inhibitor Related Encephalitis, identifying the causative agent for diagnosis."
    },
    {
      "name": "CB154",
      "type": "checkbox",
      "page": 4,
      "field_label": "Other:",
      "question": "Was an 'Other' immune checkpoint-inhibitor the cause of the encephalitis?",
      "context": "Sub-question for Immune Checkpoint-Inhibitor Related Encephalitis, allowing specification of other causative agents."
    },
    {
      "name": "T155",
      "type": "text",
      "page": 4,
      "field_label": "Other:",
      "question": "Please specify the 'Other' immune checkpoint-inhibitor that caused the encephalitis.",
      "context": "Text field to detail other specific immune checkpoint inhibitors not listed for encephalitis causation."
    },
    {
      "name": "CB156",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of refractory immune or idiopathic thrombocytopenic purpura (ITP)?",
      "context": "Primary question for Immune or Idiopathic Thrombocytopenic Purpura, confirming diagnosis for treatment."
    },
    {
      "name": "CB158",
      "type": "checkbox",
      "page": 4,
      "field_label": "refractory immune thrombocytopenic purpura",
      "question": "Does the patient have refractory immune thrombocytopenic purpura?",
      "context": "Sub-question for Immune or Idiopathic Thrombocytopenic Purpura, specifying if the ITP is unresponsive to prior treatment."
    },
    {
      "name": "CB159",
      "type": "checkbox",
      "page": 4,
      "field_label": "idiopathic thrombocytopenic purpura (ITP)",
      "question": "Does the patient have idiopathic thrombocytopenic purpura (ITP)?",
      "context": "Sub-question for Immune or Idiopathic Thrombocytopenic Purpura, specifying the type of purpura."
    },
    {
      "name": "CB157",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Does the patient NOT have a documented diagnosis of refractory immune or idiopathic thrombocytopenic purpura (ITP)?",
      "context": "Primary question for Immune or Idiopathic Thrombocytopenic Purpura, confirming diagnosis for treatment."
    },
    {
      "name": "CB160",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Is Rituxan (rituximab) being used as rejection prophylaxis in sensitized kidney transplant recipients with donor specific antibodies?",
      "context": "Primary question for Kidney Transplant Rejection Prophylaxis, confirming Rituxan's use in high-risk patients."
    },
    {
      "name": "CB161",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Is Rituxan (rituximab) NOT being used as rejection prophylaxis in sensitized kidney transplant recipients with donor specific antibodies?",
      "context": "Primary question for Kidney Transplant Rejection Prophylaxis, confirming Rituxan's use in high-risk patients."
    },
    {
      "name": "CB162",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of lymphocyte-predominant Hodgkin's lymphoma?",
      "context": "Primary question for Lymphocyte-Predominant Hodgkin's Lymphoma, confirming diagnosis for treatment eligibility."
    },
    {
      "name": "CB163",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Does the patient NOT have a documented diagnosis of lymphocyte-predominant Hodgkin's lymphoma?",
      "context": "Primary question for Lymphocyte-Predominant Hodgkin's Lymphoma, confirming diagnosis for treatment eligibility."
    },
    {
      "name": "CB164",
      "type": "checkbox",
      "page": 4,
      "field_label": "Relapsing-remitting MS (RRMS)",
      "question": "Has the patient been diagnosed with Relapsing-remitting MS (RRMS)?",
      "context": "Sub-question for Multiple Sclerosis, specifying the patient's diagnosed MS type for treatment context."
    },
    {
      "name": "CB165",
      "type": "checkbox",
      "page": 4,
      "field_label": "Secondary-progressive MS (SPMS)",
      "question": "Has the patient been diagnosed with Secondary-progressive MS (SPMS)?",
      "context": "Sub-question for Multiple Sclerosis, specifying the patient's diagnosed MS type for treatment context."
    },
    {
      "name": "CB166",
      "type": "checkbox",
      "page": 4,
      "field_label": "Primary-progressive MS (PPMS)",
      "question": "Has the patient been diagnosed with Primary-progressive MS (PPMS)?",
      "context": "Sub-question for Multiple Sclerosis, specifying the patient's diagnosed MS type for treatment context."
    },
    {
      "name": "CB167",
      "type": "checkbox",
      "page": 4,
      "field_label": "Progressive-relapsing MS (PRMS)",
      "question": "Has the patient been diagnosed with Progressive-relapsing MS (PRMS)?",
      "context": "Sub-question for Multiple Sclerosis, specifying the patient's diagnosed MS type for treatment context."
    },
    {
      "name": "CB168",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Has the patient discontinued other medications used for treating MS (not including Ampyra)?",
      "context": "Follow-up question for Multiple Sclerosis, indicating prior treatment history and potential reasons for change."
    },
    {
      "name": "CB169",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Has the patient NOT discontinued other medications used for treating MS (not including Ampyra)?",
      "context": "Follow-up question for Multiple Sclerosis, indicating prior treatment history and potential reasons for change."
    },
    {
      "name": "CB170",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)?",
      "context": "Primary question for Myasthenia Gravis (MuSK-MG), confirming diagnosis for treatment eligibility."
    },
    {
      "name": "CB172",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Has the patient had an unsatisfactory response to initial immunotherapy for MuSK-MG?",
      "context": "Follow-up question for Myasthenia Gravis (MuSK-MG), assessing failure of first-line treatments."
    },
    {
      "name": "CB173",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Has the patient NOT had an unsatisfactory response to initial immunotherapy for MuSK-MG?",
      "context": "Follow-up question for Myasthenia Gravis (MuSK-MG), assessing failure of first-line treatments."
    },
    {
      "name": "CB171",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Does the patient NOT have a documented diagnosis of muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)?",
      "context": "Primary question for Myasthenia Gravis (MuSK-MG), confirming diagnosis for treatment eligibility."
    },
    {
      "name": "CB174",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of neuromyelitis optica (Devic's disease)?",
      "context": "Primary question for Neuromyelitis Optica (Devic's disease), confirming diagnosis for treatment eligibility."
    },
    {
      "name": "CB175",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Does the patient NOT have a documented diagnosis of neuromyelitis optica (Devic's disease)?",
      "context": "Primary question for Neuromyelitis Optica (Devic's disease), confirming diagnosis for treatment eligibility."
    },
    {
      "name": "CB176",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Was the treatment with at least one immunotherapy ineffective for neuromyelitis optica?",
      "context": "Follow-up question for Neuromyelitis Optica, assessing prior treatment failure with immunotherapy."
    },
    {
      "name": "CB177",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Was the treatment with at least one immunotherapy NOT ineffective for neuromyelitis optica?",
      "context": "Follow-up question for Neuromyelitis Optica, assessing prior treatment failure with immunotherapy."
    },
    {
      "name": "CB178",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma?",
      "context": "Primary question for Opsoclonus-Myoclonus-Ataxia, confirming diagnosis and association for treatment eligibility."
    },
    {
      "name": "CB179",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Does the patient NOT have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma?",
      "context": "Primary question for Opsoclonus-Myoclonus-Ataxia, confirming diagnosis and association for treatment eligibility."
    },
    {
      "name": "CB180",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Is the patient refractory to steroids, chemotherapy, and intravenous immunoglobulins for OMA?",
      "context": "Follow-up question for Opsoclonus-Myoclonus-Ataxia, assessing failure of multiple prior treatment lines."
    },
    {
      "name": "T189",
      "type": "text",
      "page": 4,
      "field_label": "Medication:",
      "question": "What is the name of the first medication tried for OMA?",
      "context": "Details of prior medications used for Opsoclonus-Myoclonus-Ataxia, essential for demonstrating refractoriness."
    },
    {
      "name": "T190",
      "type": "text",
      "page": 4,
      "field_label": "Date: (MM)",
      "question": "What is the month the first medication was started for OMA?",
      "context": "Month of administration for the first prior medication used for OMA, indicating treatment timeline."
    },
    {
      "name": "T191",
      "type": "text",
      "page": 4,
      "field_label": "Date: (DD)",
      "question": "What is the day the first medication was started for OMA?",
      "context": "Day of administration for the first prior medication used for OMA, indicating treatment timeline."
    },
    {
      "name": "T192",
      "type": "text",
      "page": 4,
      "field_label": "Date: (YYYY)",
      "question": "What is the year the first medication was started for OMA?",
      "context": "Year of administration for the first prior medication used for OMA, indicating treatment timeline."
    },
    {
      "name": "T193",
      "type": "text",
      "page": 4,
      "field_label": "Date: (MM)",
      "question": "What is the month the first medication was ended for OMA?",
      "context": "Month of cessation for the first prior medication used for OMA, indicating treatment timeline."
    },
    {
      "name": "T194",
      "type": "text",
      "page": 4,
      "field_label": "Date: (DD)",
      "question": "What is the day the first medication was ended for OMA?",
      "context": "Day of cessation for the first prior medication used for OMA, indicating treatment timeline."
    },
    {
      "name": "T195",
      "type": "text",
      "page": 4,
      "field_label": "Date: (YYYY)",
      "question": "What is the year the first medication was ended for OMA?",
      "context": "Year of cessation for the first prior medication used for OMA, indicating treatment timeline."
    },
    {
      "name": "T196",
      "type": "text",
      "page": 4,
      "field_label": "Medication:",
      "question": "What is the name of the second medication tried for OMA?",
      "context": "Details of prior medications used for Opsoclonus-Myoclonus-Ataxia, essential for demonstrating refractoriness."
    },
    {
      "name": "T197",
      "type": "text",
      "page": 4,
      "field_label": "Date: (MM)",
      "question": "What is the month the second medication was started for OMA?",
      "context": "Month of administration for the second prior medication used for OMA, indicating treatment timeline."
    },
    {
      "name": "T198",
      "type": "text",
      "page": 4,
      "field_label": "Date: (DD)",
      "question": "What is the day the second medication was started for OMA?",
      "context": "Day of administration for the second prior medication used for OMA, indicating treatment timeline."
    },
    {
      "name": "T199",
      "type": "text",
      "page": 4,
      "field_label": "Date: (YYYY)",
      "question": "What is the year the second medication was started for OMA?",
      "context": "Year of administration for the second prior medication used for OMA, indicating treatment timeline."
    },
    {
      "name": "T200",
      "type": "text",
      "page": 4,
      "field_label": "Date: (MM)",
      "question": "What is the month the second medication was ended for OMA?",
      "context": "Month of cessation for the second prior medication used for OMA, indicating treatment timeline."
    },
    {
      "name": "T201",
      "type": "text",
      "page": 4,
      "field_label": "Date: (DD)",
      "question": "What is the day the second medication was ended for OMA?",
      "context": "Day of cessation for the second prior medication used for OMA, indicating treatment timeline."
    },
    {
      "name": "T202",
      "type": "text",
      "page": 4,
      "field_label": "Date: (YYYY)",
      "question": "What is the year the second medication was ended for OMA?",
      "context": "Year of cessation for the second prior medication used for OMA, indicating treatment timeline."
    },
    {
      "name": "CB181",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Is the patient NOT refractory to steroids, chemotherapy, and intravenous immunoglobulins for OMA?",
      "context": "Follow-up question for Opsoclonus-Myoclonus-Ataxia, assessing failure of multiple prior treatment lines."
    },
    {
      "name": "CB203",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Is Rituxan (rituximab) being used as treatment of post-transplant lymphoproliferative disorder?",
      "context": "Primary question for Post-transplant Lymphoproliferative Disorder, confirming Rituxan's use as treatment."
    },
    {
      "name": "CB204",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Is Rituxan (rituximab) NOT being used as treatment of post-transplant lymphoproliferative disorder?",
      "context": "Primary question for Post-transplant Lymphoproliferative Disorder, confirming Rituxan's use as treatment."
    },
    {
      "name": "CB205",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Is Rituxan (rituximab) being used as prophylaxis for Epstein-Barr virus (EBV) post-transplant lymphoproliferative disorder?",
      "context": "Follow-up question for Post-transplant Lymphoproliferative Disorder, confirming Rituxan's use for EBV prophylaxis."
    },
    {
      "name": "CB206",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Is Rituxan (rituximab) NOT being used as prophylaxis for Epstein-Barr virus (EBV) post-transplant lymphoproliferative disorder?",
      "context": "Follow-up question for Post-transplant Lymphoproliferative Disorder, confirming Rituxan's use for EBV prophylaxis."
    }
  ],
  "5": [
    {
      "name": "T12",
      "type": "text",
      "page": 5,
      "field_label": "Patient First Name",
      "question": "What is the patient's first name?",
      "context": "Patient demographic information for identification purposes in the clinical information section."
    },
    {
      "name": "T13",
      "type": "text",
      "page": 5,
      "field_label": "Patient Last Name",
      "question": "What is the patient's last name?",
      "context": "Patient demographic information for identification purposes in the clinical information section."
    },
    {
      "name": "T19",
      "type": "text",
      "page": 5,
      "field_label": "Patient Phone",
      "question": "What is the patient's phone number?",
      "context": "Patient contact information for communication regarding the prior authorization request."
    },
    {
      "name": "T14",
      "type": "text",
      "page": 5,
      "field_label": "Patient DOB (MM/DD/YYYY)",
      "question": "What is the patient's date of birth?",
      "context": "Patient demographic information for identification and age verification purposes."
    },
    {
      "name": "CB207",
      "type": "checkbox",
      "page": 5,
      "field_label": "Mild",
      "question": "Is the patient's rheumatoid arthritis considered mild?",
      "context": "Indicates the severity level of the patient's rheumatoid arthritis for treatment eligibility."
    },
    {
      "name": "CB208",
      "type": "checkbox",
      "page": 5,
      "field_label": "Moderate",
      "question": "Is the patient's rheumatoid arthritis considered moderate?",
      "context": "Indicates the severity level of the patient's rheumatoid arthritis for treatment eligibility."
    },
    {
      "name": "CB209",
      "type": "checkbox",
      "page": 5,
      "field_label": "Severe",
      "question": "Is the patient's rheumatoid arthritis considered severe?",
      "context": "Indicates the severity level of the patient's rheumatoid arthritis for treatment eligibility."
    },
    {
      "name": "CB210",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Is there evidence that the disease is active?",
      "context": "Confirms active disease state of rheumatoid arthritis, crucial for justifying treatment initiation."
    },
    {
      "name": "CB211",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Is there no evidence that the disease is active?",
      "context": "Indicates lack of active disease state of rheumatoid arthritis, may impact treatment approval."
    },
    {
      "name": "CB212",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Will Rituxan (rituximab) be used in combination with methotrexate?",
      "context": "Determines if the requested drug will be part of a combination therapy for rheumatoid arthritis."
    },
    {
      "name": "CB213",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Will Rituxan (rituximab) not be used in combination with methotrexate?",
      "context": "Indicates Rituxan will be used as monotherapy or with other agents for rheumatoid arthritis."
    },
    {
      "name": "CB214",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Has treatment with methotrexate been ineffective, not tolerated or contraindicated?",
      "context": "Assesses the patient's response or tolerance to prior methotrexate therapy, a prerequisite for Rituxan."
    },
    {
      "name": "CB216",
      "type": "checkbox",
      "page": 5,
      "field_label": "ineffective",
      "question": "Was methotrexate treatment ineffective?",
      "context": "Specifies the reason for methotrexate failure, indicating the drug did not achieve desired clinical outcome."
    },
    {
      "name": "CB217",
      "type": "checkbox",
      "page": 5,
      "field_label": "not tolerated",
      "question": "Was methotrexate treatment not tolerated?",
      "context": "Specifies the reason for methotrexate failure, indicating patient experienced adverse effects."
    },
    {
      "name": "CB218",
      "type": "checkbox",
      "page": 5,
      "field_label": "contraindicated",
      "question": "Was methotrexate treatment contraindicated?",
      "context": "Specifies the reason for methotrexate failure, indicating medical reasons prevented its use."
    },
    {
      "name": "CB215",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Has treatment with methotrexate not been ineffective, not tolerated or contraindicated?",
      "context": "Indicates that methotrexate therapy was effective, tolerated, and not contraindicated."
    },
    {
      "name": "CB223",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Was treatment with another conventional DMARD ineffective?",
      "context": "Assesses the patient's response to other prior conventional DMARDs, a prerequisite for Rituxan."
    },
    {
      "name": "CB225",
      "type": "checkbox",
      "page": 5,
      "field_label": "azathioprine",
      "question": "Was azathioprine ineffective?",
      "context": "Indicates if azathioprine, a conventional DMARD, failed to control the patient's condition."
    },
    {
      "name": "CB226",
      "type": "checkbox",
      "page": 5,
      "field_label": "cyclosporine",
      "question": "Was cyclosporine ineffective?",
      "context": "Indicates if cyclosporine, a conventional DMARD, failed to control the patient's condition."
    },
    {
      "name": "CB227",
      "type": "checkbox",
      "page": 5,
      "field_label": "hydroxychloroquine",
      "question": "Was hydroxychloroquine ineffective?",
      "context": "Indicates if hydroxychloroquine, a conventional DMARD, failed to control the patient's condition."
    },
    {
      "name": "CB228",
      "type": "checkbox",
      "page": 5,
      "field_label": "leflunomide",
      "question": "Was leflunomide ineffective?",
      "context": "Indicates if leflunomide, a conventional DMARD, failed to control the patient's condition."
    },
    {
      "name": "CB229",
      "type": "checkbox",
      "page": 5,
      "field_label": "sulfasalazine",
      "question": "Was sulfasalazine ineffective?",
      "context": "Indicates if sulfasalazine, a conventional DMARD, failed to control the patient's condition."
    },
    {
      "name": "CB224",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Was treatment with another conventional DMARD not ineffective?",
      "context": "Indicates that other conventional DMARD therapy was effective or tolerated."
    },
    {
      "name": "CB281",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of Sjögren's syndrome?",
      "context": "Confirms the primary diagnosis for which Rituxan is being requested, supporting medical necessity."
    },
    {
      "name": "CB282",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Does the patient not have a documented diagnosis of Sjögren's syndrome?",
      "context": "Indicates the absence of Sjögren's syndrome diagnosis, affecting treatment eligibility."
    },
    {
      "name": "CB283",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Was treatment with corticosteroids and other immunosuppressive agents ineffective?",
      "context": "Evaluates prior therapy failure for Sjögren's syndrome, justifying advanced treatment like Rituxan."
    },
    {
      "name": "T285",
      "type": "text",
      "page": 5,
      "field_label": "Medication:",
      "question": "What is the name of the first corticosteroid or immunosuppressive agent used?",
      "context": "Details the specific prior medication used and its failure for Sjögren's syndrome management."
    },
    {
      "name": "T286",
      "type": "text",
      "page": 5,
      "field_label": "Date: (MM)",
      "question": "What is the month the first medication was started?",
      "context": "Month of administration for the first corticosteroid/immunosuppressive agent in Sjögren's syndrome."
    },
    {
      "name": "T287",
      "type": "text",
      "page": 5,
      "field_label": "Date: (DD)",
      "question": "What is the day the first medication was started?",
      "context": "Day of administration for the first corticosteroid/immunosuppressive agent in Sjögren's syndrome."
    },
    {
      "name": "T288",
      "type": "text",
      "page": 5,
      "field_label": "Date: (YYYY)",
      "question": "What is the year the first medication was started?",
      "context": "Year of administration for the first corticosteroid/immunosuppressive agent in Sjögren's syndrome."
    },
    {
      "name": "T289",
      "type": "text",
      "page": 5,
      "field_label": "Date: (MM)",
      "question": "What is the month the first medication was ended?",
      "context": "Month of cessation for the first corticosteroid/immunosuppressive agent in Sjögren's syndrome."
    },
    {
      "name": "T290",
      "type": "text",
      "page": 5,
      "field_label": "Date: (DD)",
      "question": "What is the day the first medication was ended?",
      "context": "Day of cessation for the first corticosteroid/immunosuppressive agent in Sjögren's syndrome."
    },
    {
      "name": "T291",
      "type": "text",
      "page": 5,
      "field_label": "Date: (YYYY)",
      "question": "What is the year the first medication was ended?",
      "context": "Year of cessation for the first corticosteroid/immunosuppressive agent in Sjögren's syndrome."
    },
    {
      "name": "T292",
      "type": "text",
      "page": 5,
      "field_label": "Medication:",
      "question": "What is the name of the second corticosteroid or immunosuppressive agent used?",
      "context": "Details the specific second prior medication used and its failure for Sjögren's syndrome management."
    },
    {
      "name": "T293",
      "type": "text",
      "page": 5,
      "field_label": "Date: (MM)",
      "question": "What is the month the second medication was started?",
      "context": "Month of administration for the second corticosteroid/immunosuppressive agent in Sjögren's syndrome."
    },
    {
      "name": "T294",
      "type": "text",
      "page": 5,
      "field_label": "Date: (DD)",
      "question": "What is the day the second medication was started?",
      "context": "Day of administration for the second corticosteroid/immunosuppressive agent in Sjögren's syndrome."
    },
    {
      "name": "T295",
      "type": "text",
      "page": 5,
      "field_label": "Date: (YYYY)",
      "question": "What is the year the second medication was started?",
      "context": "Year of administration for the second corticosteroid/immunosuppressive agent in Sjögren's syndrome."
    },
    {
      "name": "T296",
      "type": "text",
      "page": 5,
      "field_label": "Date: (MM)",
      "question": "What is the month the second medication was ended?",
      "context": "Month of cessation for the second corticosteroid/immunosuppressive agent in Sjögren's syndrome."
    },
    {
      "name": "T297",
      "type": "text",
      "page": 5,
      "field_label": "Date: (DD)",
      "question": "What is the day the second medication was ended?",
      "context": "Day of cessation for the second corticosteroid/immunosuppressive agent in Sjögren's syndrome."
    },
    {
      "name": "T298",
      "type": "text",
      "page": 5,
      "field_label": "Date: (YYYY)",
      "question": "What is the year the second medication was ended?",
      "context": "Year of cessation for the second corticosteroid/immunosuppressive agent in Sjögren's syndrome."
    },
    {
      "name": "CB284",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Was treatment with corticosteroids and other immunosuppressive agents not ineffective?",
      "context": "Indicates prior corticosteroid/immunosuppressive therapy was effective or tolerated for Sjögren's syndrome."
    },
    {
      "name": "CB299",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of refractory thrombotic thrombocytopenic purpura (TTP)?",
      "context": "Confirms diagnosis of refractory TTP, indicating the severity and need for specific treatment."
    },
    {
      "name": "CB300",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Does the patient not have a documented diagnosis of refractory thrombotic thrombocytopenic purpura (TTP)?",
      "context": "Indicates absence of refractory TTP diagnosis, affecting treatment eligibility for Rituxan."
    },
    {
      "name": "CB301",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of Waldenström macroglobulinemia?",
      "context": "Confirms diagnosis of Waldenström macroglobulinemia, essential for Rituxan coverage."
    },
    {
      "name": "CB302",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Does the patient not have a documented diagnosis of Waldenström macroglobulinemia?",
      "context": "Indicates absence of Waldenström macroglobulinemia diagnosis, affecting treatment eligibility."
    },
    {
      "name": "CB303",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Is this continuation request a result of the patient receiving samples of Rituxan (rituximab)?",
      "context": "Determines if the current request is for continued therapy after receiving Rituxan samples."
    },
    {
      "name": "CB304",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Is this continuation request not a result of the patient receiving samples of Rituxan (rituximab)?",
      "context": "Indicates the continuation request is for other reasons, not post-sample use."
    },
    {
      "name": "T305",
      "type": "text",
      "page": 5,
      "field_label": "Please indicate the length of time on Rituxan (rituximab):",
      "question": "What is the total length of time the patient has been on Rituxan (rituximab)?",
      "context": "Provides duration of Rituxan therapy, crucial for assessing ongoing efficacy and safety for continuation requests."
    },
    {
      "name": "CB310",
      "type": "checkbox",
      "page": 5,
      "field_label": "Mild",
      "question": "Was the severity of the disease at baseline (pretreatment with Rituxan (rituximab)) mild?",
      "context": "Assesses baseline rheumatoid arthritis severity to evaluate treatment effectiveness for continuation requests."
    },
    {
      "name": "CB311",
      "type": "checkbox",
      "page": 5,
      "field_label": "Moderate",
      "question": "Was the severity of the disease at baseline (pretreatment with Rituxan (rituximab)) moderate?",
      "context": "Assesses baseline rheumatoid arthritis severity to evaluate treatment effectiveness for continuation requests."
    },
    {
      "name": "CB312",
      "type": "checkbox",
      "page": 5,
      "field_label": "Severe",
      "question": "Was the severity of the disease at baseline (pretreatment with Rituxan (rituximab)) severe?",
      "context": "Assesses baseline rheumatoid arthritis severity to evaluate treatment effectiveness for continuation requests."
    },
    {
      "name": "CB306",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Is there clinical documentation supporting disease stability?",
      "context": "Confirms clinical documentation showing stable disease for continued Rituxan therapy in rheumatoid arthritis."
    },
    {
      "name": "CB307",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Is there no clinical documentation supporting disease stability?",
      "context": "Indicates lack of documentation for disease stability, potentially impacting Rituxan continuation for RA."
    },
    {
      "name": "CB308",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Is there clinical documentation supporting disease improvement?",
      "context": "Confirms clinical documentation showing disease improvement for continued Rituxan therapy in rheumatoid arthritis."
    },
    {
      "name": "CB309",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Is there no clinical documentation supporting disease improvement?",
      "context": "Indicates lack of documentation for disease improvement, potentially impacting Rituxan continuation for RA."
    },
    {
      "name": "CB313",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Is there clinical documentation supporting disease stability?",
      "context": "Confirms clinical documentation showing stable disease for continued Rituxan therapy for other indications."
    },
    {
      "name": "CB314",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Is there no clinical documentation supporting disease stability?",
      "context": "Indicates lack of documentation for disease stability, potentially impacting Rituxan continuation for other indications."
    },
    {
      "name": "CB315",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Is there clinical documentation supporting disease improvement?",
      "context": "Confirms clinical documentation showing disease improvement for continued Rituxan therapy for other indications."
    },
    {
      "name": "CB316",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Is there no clinical documentation supporting disease improvement?",
      "context": "Indicates lack of documentation for disease improvement, potentially impacting Rituxan continuation for other indications."
    },
    {
      "name": "T317",
      "type": "text",
      "page": 5,
      "field_label": "Date: (MM)",
      "question": "What is the month the request was completed?",
      "context": "Month of the date the prior authorization request form was signed by the prescriber."
    },
    {
      "name": "T318",
      "type": "text",
      "page": 5,
      "field_label": "Date: (DD)",
      "question": "What is the day the request was completed?",
      "context": "Day of the date the prior authorization request form was signed by the prescriber."
    },
    {
      "name": "T319",
      "type": "text",
      "page": 5,
      "field_label": "Date: (YYYY)",
      "question": "What is the year the request was completed?",
      "context": "Year of the date the prior authorization request form was signed by the prescriber."
    }
  ]
}